SBI² 2026 has ended. This guide stays up as the record of who was there. See upcoming conferences

Johnson & Johnson at SBI² 2026

Nov 2–4, 2026 Boston, MA ~300 attendees Website

Johnson & Johnson takes part in 1 session at SBI² 2026 in Boston. Its place on the program is a co-chair's seat on the scientific session about moving from novel phenotypes to decisions.

OrganizationSBI² 2026 Attendance
Johnson & Johnson
New Brunswick, NJ
Large pharma
US healthcare company developing medicines and medical technology across oncology, immunology, neuroscience and other areas.
Session
Wed Nov 4
1:30pm–4:15pm
Session 4: Applications: Novel Phenotypes to Decisions
Phenotypic screening and assays · with Arvinas

Explore the full SBI² 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Boston. Leave your work email and we’ll be in touch.

Privacy

Download the full SBI² 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Find decision makers at Johnson & Johnson

Tell us what you sell and we’ll find the people at Johnson & Johnson most likely to buy it.

  • Who to contact
  • Their contact info
  • What to say
  • Free, no sign-up

Not affiliated with or endorsed by the Society of Biomolecular Imaging and Informatics. Submit a correction